- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Aliquots are pre-aliquoted, commercially available drugs from the EU. Our aliquots thus contain therapeutic molecules manufactured by the original drug license holder and repackaged by Evidentic.
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD80 , CD86 |
Fusion protein |
Orencia® |
25 mg/mL |
yes |
5 mg |
-80°C |
02/2023 |
194,40 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
11/2023 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
09/2018 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2018 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
07/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2020 |
394,20 € |
||
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
03/2022 |
262,80 € |
||
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
05/2023 |
262,80 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
03/2021 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
07/2024 |
206,00 € |
||
IL-13 , IL-4 |
Monoclonal Antibody |
Dupixent® |
150 mg/mL |
yes |
12 mg |
-80°C |
11/2024 |
375,00 € |
||
C5 complement protein |
Monoclonal Antibody |
Soliris® |
10 mg/mL |
yes |
4 mg |
-80°C |
04/2022 |
652,50 € |
||
IL-23 |
Monoclonal Antibody |
Tremfya® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2023 |
615,60 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
yes |
2 mg |
-80°C |
11/2024 |
208,00 € |
||
CTLA-4 |
Monoclonal Antibody |
Yervoy® |
5 mg/mL |
yes |
2 mg |
-80°C |
09/2024 |
848,00 € |
||
CTLA-4 |
Monoclonal Antibody |
Yervoy® |
5 mg/mL |
yes |
2 mg |
-80°C |
08/2021 |
763,20 € |
||
CD20 |
Monoclonal Antibody |
Ocrevus® |
30 mg/mL |
yes |
3 mg |
-80°C |
02/2021 |
395,10 € |
||
CD20 |
Monoclonal Antibody |
Ocrevus® |
30 mg/mL |
yes |
3 mg |
-80 °C |
09/2022 |
395,10 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
04/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
06/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
10/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
02/2020 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
08/2020 |
391,50 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
yes |
2 mg |
-80°C |
04/2022 |
564,30 € |
||
HER2 |
Monoclonal Antibody |
Perjeta® |
30 mg/mL |
yes |
6 mg |
-80°C |
11/2020 |
419,40 € |
||
IL-23 |
Monoclonal Antibody |
Skyrizi® |
150 mg/mL |
yes |
6 mg |
-80°C |
04/2023 |
931,50 € |
||
IL-23 |
Monoclonal Antibody |
Skyrizi® |
150 mg/mL |
yes |
6 mg |
-80°C |
03/2024 |
931,50 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin